OKYO Pharma Ltd. Form 6-K Summary
Business Context and Reporting Period
OKYO Pharma Ltd., a foreign private issuer reporting on Form 20-F, furnished this Form 6-K on May 18, 2022. The filing reports that the company issued a U.S. news service announcement concerning a dealing by a person discharging managerial responsibilities (PDMR).
Financial Metrics and Liquidity
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, guidance, or other operating or financial metrics.
Material Changes Versus Prior Period
No financial or operating-period comparison is provided. The reported event is a PDMR dealing; the filing text does not provide the transaction details, number of securities, price, or resulting ownership position.
Outlook, Risks, and Unusual Items
The filing contains no management outlook, risk-factor update, contingencies, or unusual accounting items. Exhibit 99.1 is identified as a news service announcement dated May 18, 2022, but its substantive contents are not included in the provided filing text.
Investor Verification Points
- Review Exhibit 99.1 to determine the identity of the PDMR and the details of the dealing.
- Verify the type, quantity, price, and date of the securities transaction.
- Confirm the PDMR’s resulting ownership or control position, if disclosed.
- Note that the exhibit was furnished and was not deemed filed under Section 18 of the Securities Exchange Act, nor incorporated by reference except as expressly specified.